[go: up one dir, main page]

MD348C2 - Transdermal therapeutic system and method for obtaining thereof - Google Patents

Transdermal therapeutic system and method for obtaining thereof

Info

Publication number
MD348C2
MD348C2 MD94-0291A MD940291A MD348C2 MD 348 C2 MD348 C2 MD 348C2 MD 940291 A MD940291 A MD 940291A MD 348 C2 MD348 C2 MD 348C2
Authority
MD
Moldova
Prior art keywords
layer
weight
basis
active substance
tank
Prior art date
Application number
MD94-0291A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD348B1 (en
Inventor
Hille Thomas
Hoffmann Hans-Rainer
Huber Hans-Joachim
Knoch Axel
Schneider Gerhard
Stanislaus Fritz
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh & Co.Kg
Klinge Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3843238A external-priority patent/DE3843238C1/de
Application filed by Lts Lohmann Therapie-Systeme Gmbh & Co.Kg, Klinge Pharma Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh & Co.Kg
Publication of MD348B1 publication Critical patent/MD348B1/en
Publication of MD348C2 publication Critical patent/MD348C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to the transdermal therapeutics system for the application of the remedy onto the skin, consisting of an impenetrable covering layer for the active substance, a glucy tank layer, a depot layer, contacting with the tank layer, and if necessary, a detaching protecting layer, the tank layer containing from 70 to 90 weight percent of polymeric material, selected from the group of block copolymers on the basis of styrene and 1,3-dienes, polyisobutylene, polymers on the basis of acrylate and /or methacrylate and hydrogenated resin esters; after the preparation, the active substance depot contains from 45 to 60 weight % of physostigmine solution of 25-30 weight %.Drawings: 6
MD94-0291A 1988-12-22 1994-07-12 Transdermal therapeutic system and method for obtaining thereof MD348C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3843238A DE3843238C1 (en) 1988-12-22 1988-12-22
SU894742774A RU2052997C1 (en) 1988-12-22 1989-12-21 Transdermal therapeutic system for medicinal agent application and a method of its preparing

Publications (2)

Publication Number Publication Date
MD348B1 MD348B1 (en) 1995-12-31
MD348C2 true MD348C2 (en) 1996-04-30

Family

ID=25875482

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0291A MD348C2 (en) 1988-12-22 1994-07-12 Transdermal therapeutic system and method for obtaining thereof

Country Status (1)

Country Link
MD (1) MD348C2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cerere nr. 3409079, DE, Int. Cl. A 61 L 15/06, 15/03 1985. *
Cerere nr. 3629304, DE, Int. Cl. A 61 L 15/03, 1988. *

Also Published As

Publication number Publication date
MD348B1 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
ATE105488T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH PHYSOSTIGMINE AS AN ACTIVE INGREDIENT AND PROCESS FOR ITS PRODUCTION.
MY105279A (en) Transdermal therapeutic system comprising tulobuterol as active substance.
IL138005A0 (en) Transdermal therapeutic system (tts) containing pergolide
YU240689A (en) Process for making transdermal therapy system with phisostigmine as active component
MD348C2 (en) Transdermal therapeutic system and method for obtaining thereof
MD937C2 (en) Transdermal therapeutic system for cutaneous application of physostigmine on the skin and process for obtaining it
MD107C2 (en) Transdermal therapeutical system

Legal Events

Date Code Title Description
CHPR Change of proprietorship

Free format text: LTS LOHMANN THERAPIE-SYSTEME GMBH & CO.KG, DE

IF99 Valid patent on 19990615

Free format text: EXPIRES: 20091221